We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+39.01%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$5.73M
AUM Growth
+$710K
Cap. Flow
-$413K
Cap. Flow %
-7.21%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ADCT icon
ADC Therapeutics
ADCT
+$353K
2
KYNB
Kyntra Bio
KYNB
+$60.6K

Sector Composition

Rank Sector Weight
1 Healthcare 59.46%
2 Industrials 40.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BW icon
1
Babcock & Wilcox
BW
$1.64B
$2.32M 40.54%
2,416,200
– –
ADCT icon
2
ADC Therapeutics
ADCT
$155M
$1.83M 31.92%
682,998
-167,739
-20% -$353K
CBUS icon
3
Cibus
CBUS
$136M
$1.58M 27.53%
1,143,949
– –
KYNB
4
Kyntra Bio
KYNB
$28.6M
– –
-7,828
Closed -$60.6K

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q2 2025 Portfolio in Review

As of Q2 2025, Vantage Consulting Group held 4 positions worth $5.73M, up 14% from $5.02M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vantage Consulting Group withdrew a net $413K in Q2 2025, closing 1 position and reducing 1 holding. Its most notable exit was Kyntra Bio, an estimated $60.6K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 68% a quarter earlier, followed by Industrials.

  • Vantage Consulting Group's biggest Q2 2025 reduction was ADC Therapeutics, cutting an estimated $353K.
  • Vantage Consulting Group fully exited Kyntra Bio in Q2 2025, selling an estimated $60.6K.
  • Vantage Consulting Group's ten largest holdings make up 100% of its $5.73M portfolio in Q2 2025.
  • Vantage Consulting Group opened 0 new positions and closed 1 in Q2 2025.
  • Vantage Consulting Group's portfolio value rose 14% quarter-over-quarter to $5.73M.

Based on Vantage Consulting Group's 13F filing for Q2 2025, filed 12 Aug 2025.